These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 32067282)

  • 1. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.
    Song Y; Song C; Yang S
    Cancer Biother Radiopharm; 2018 Jun; 33(5):203-211. PubMed ID: 29916747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling.
    Jiang J; Lu J; Wang X; Sun B; Liu X; Ding Y; Gao G
    Aging (Albany NY); 2021 Jul; 13(15):19243-19259. PubMed ID: 34233294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
    Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
    J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
    Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
    Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-30a inhibits glioma progression and stem cell‑like properties by repression of Wnt5a.
    Zhang Y; Wu Z; Li L; Xie M
    Oncol Rep; 2017 Aug; 38(2):1156-1162. PubMed ID: 28627699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
    Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
    Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
    Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
    Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer.
    Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z
    Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated microRNA-30b-3p inhibits proliferation, invasion and migration of glioma cells via inactivation of the AKT signaling pathway by up-regulating RECK.
    Jian Y; Xu CH; Li YP; Tang B; Xie SH; Zeng EM
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31270250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-30a regulates cell proliferation and tumor growth of colorectal cancer by targeting CD73.
    Xie M; Qin H; Luo Q; Huang Q; He X; Yang Z; Lan P; Lian L
    BMC Cancer; 2017 May; 17(1):305. PubMed ID: 28464916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma.
    Wang ZF; Liao F; Wu H; Dai J
    J Exp Clin Cancer Res; 2019 May; 38(1):201. PubMed ID: 31101062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.
    Song H; Zhang Y; Liu N; Zhao S; Kong Y; Yuan L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircMMP1 promotes the progression of glioma through miR-433/HMGB3 axis in vitro and in vivo.
    Yin K; Liu X
    IUBMB Life; 2020 Nov; 72(11):2508-2524. PubMed ID: 32918539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.